0001209191-20-065220.txt : 20201228
0001209191-20-065220.hdr.sgml : 20201228
20201228170753
ACCESSION NUMBER: 0001209191-20-065220
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20201222
FILED AS OF DATE: 20201228
DATE AS OF CHANGE: 20201228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Macdonald Alistair
CENTRAL INDEX KEY: 0001624073
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36730
FILM NUMBER: 201419067
MAIL ADDRESS:
STREET 1: C/O SYNEOS HEALTH, INC.
STREET 2: 1030 SYNC STREET
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syneos Health, Inc.
CENTRAL INDEX KEY: 0001610950
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 273403111
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1030 SYNC STREET
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-876-9300
MAIL ADDRESS:
STREET 1: 1030 SYNC STREET
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: INC Research Holdings, Inc.
DATE OF NAME CHANGE: 20140616
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-22
0
0001610950
Syneos Health, Inc.
SYNH
0001624073
Macdonald Alistair
C/O SYNEOS HEALTH, INC.
1030 SYNC STREET
MORRISVILLE
NC
27560
1
1
0
0
Chief Executive Officer
Class A Common Stock
2020-12-22
4
S
0
1200
70.017
D
245487
D
Class A Common Stock
2020-12-23
4
S
0
300
70.518
D
245187
D
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2020.
The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.06, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $70.17 to $70.76, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
/s/ Sara Epstein, Attorney-in-Fact
2020-12-28
EX-24.4_951859
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Known all by these presents, that the undersigned hereby constitutes and
appoints each of Jonathan Olefson, Jason Meggs and Sara Epstein, and each of
them acting alone, signing singly, the undersigned's true and lawful
attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer, director and/or 10% or more stockholder of
Syneos Health, Inc. (the "Company"), Forms ID, 3, 4, 5 and Update Passphrase
Acknowledgement (and any amendments thereto) in accordance with Section 16(a) of
the Securities Exchange Act of 1934, as amended (the "1934 Act"), and the rules
promulgated thereunder; (2) do and perform any and all acts for and on behalf of
the undersigned which may be necessary or desirable to complete and execute any
such Form ID, 3, 4, 5 and Update Passphrase Acknowledgement (and any amendments
thereto) and to file timely such form with the United States Securities and
Exchange Commission and any stock exchange or similar authority; and (3) take
any other action of any type whatsoever in connection with the foregoing which
in the opinion of such attorney-in-fact may be of benefit to, in the best
interest of, or legally required by, the undersigned, it being understood that
the documents executed by such attorney-in-fact on behalf of the undersigned
pursuant to this Power of Attorney shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the 1934 Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms ID, 3, 4 and 5 with respect to
the undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to each of the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 15th day of November 2019.
/s/ Alistair Macdonald
Alistair Macdonald